These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16050017)

  • 1. Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells.
    Harada K; Supriatno ; Kawashima Y; Itashiki Y; Yoshida H; Sato M
    Oral Oncol; 2005 Jul; 41(6):623-30. PubMed ID: 16050017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of SKP2 induces apoptosis in lung-cancer cells.
    Yokoi S; Yasui K; Iizasa T; Takahashi T; Fujisawa T; Inazawa J
    Cancer Sci; 2003 Apr; 94(4):344-9. PubMed ID: 12824902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer.
    Uddin S; Ahmed M; Hussain AR; Jehan Z; Al-Dayel F; Munkarah A; Bavi P; Al-Kuraya KS
    Lab Invest; 2009 Oct; 89(10):1115-27. PubMed ID: 19636294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
    Supriatno ; Harada K; Yoshida H; Sato M
    Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells.
    Lee SH; McCormick F
    J Mol Med (Berl); 2005 Apr; 83(4):296-307. PubMed ID: 15605273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo.
    Wei Z; Jiang X; Liu F; Qiao H; Zhou B; Zhai B; Zhang L; Zhang X; Han L; Jiang H; Krissansen GW; Sun X
    Tumour Biol; 2013 Feb; 34(1):181-92. PubMed ID: 23229098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line.
    Supriatno ; Harada K; Kawaguchi S; Yoshida H; Sato M
    Oncol Rep; 2003; 10(3):527-32. PubMed ID: 12684618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.
    Iskandarani A; Bhat AA; Siveen KS; Prabhu KS; Kuttikrishnan S; Khan MA; Krishnankutty R; Kulinski M; Nasr RR; Mohammad RM; Uddin S
    J Transl Med; 2016 Mar; 14():69. PubMed ID: 26956626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.
    Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M
    Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
    Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
    Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
    Huang HC; Way TD; Lin CL; Lin JK
    Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
    Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
    Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H
    Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.
    Fang L; Hu Q; Hua Z; Li S; Dong W
    Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo.
    Katagiri Y; Hozumi Y; Kondo S
    J Dermatol Sci; 2006 Jun; 42(3):215-24. PubMed ID: 16504485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
    Wang L; Ye X; Cai X; Su J; Ma R; Yin X; Zhou X; Li H; Wang Z
    Oncotarget; 2015 Jul; 6(20):18027-37. PubMed ID: 26046466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.